At the heart of our work is clinical expertise. Our vitiligo medical advisory board brings together UK‑based clinicians, researchers and scientists who support and advise The Vitiligo Society. Together, they provide independent insight that helps shape our research priorities and evidence‑based work.

Rather than operating at a distance, board members kindly donate their time and knowledge to the charity. In practice, this means offering clinical perspective to ensure our information remains accurate, responsible and up to date. In doing so, they help strengthen understanding of vitiligo and its wider impact.

Alongside lived experience, medical insight plays a vital role in our work. By working closely with Trustees and staff, the advisory board strengthens our advocacy, research and policy engagement. As a result, our work reflects both patient experience and current clinical understanding.

A wide range of clinical and academic expertise sits across the advisory board. Collectively, members advise on dermatology‑related research, psychological impact and emerging treatment developments.

In addition to advisory input, members may contribute to VitLife articles, webinars and research discussions. Where appropriate, they help explain complex topics in clear and accessible language for our community.

Members of our advisory board are active within clinical research, publishing in peer‑reviewed journals such as the British Journal of Dermatology.

Beyond formal meetings, advisory board members support a wide range of research‑ and treatment‑focused activity across the Society. For example, they contribute clinical insight to articles that explore new research, treatment options and unanswered patient questions.

At the same time, their involvement informs our wider work across research and treatment content, including our member magazine, The VitLife. In addition, it supports engagement with healthcare professionals, researchers and policy discussions.

Ultimately, the vitiligo medical advisory board ensures our work remains clinically informed, evidence‑led and focused on improving outcomes for people affected by vitiligo.